Exploring the UK's Rising Biotech: Bactobio
How Bactobio is revolutionizing biotechnology with breakthrough solutions for AMR and sustainable agriculture.

Bactobio is at the forefront of innovation in microbial biotechnology, addressing urgent global issues like antimicrobial resistance (AMR) and sustainable agriculture.
The rising biotech company based in South East London recently caught our eye by making their way on to LinkedIn’s UK Top Startups Awards. LinkedIn’s UK Top Startup Awards highlight the fastest-growing and most innovative startups across the UK. The awards recognize companies that have demonstrated exceptional growth, potential, and impact, showcasing their ability to attract talent and investors. Startups are evaluated based on factors such as employee growth, jobseeker interest, and engagement. The list celebrates a wide range of industries, from tech and health to sustainability, offering insights into the most exciting companies shaping the future of the UK business landscape.
By harnessing the untapped potential of “unculturable” microbes, Bactobio is pioneering the development of novel antimicrobials to combat AMR—a critical global health threat. Their groundbreaking work has earned support through prestigious grants and partnerships, such as collaborations with Innovate UK and Crop Health and Protection (CHAP).
Using advanced data science, Bactobio is unlocking the vast, largely unstudied microbial “dark matter” to create sustainable solutions in medicine, agriculture, and beyond. Their approach, blending computational biology with microbial genomics, not only holds promise for pharmaceutical advancements but also has transformative potential for eco-friendly agriculture.
In short, Bactobio represents the future of industrial biotechnology, providing scalable, natural solutions to global challenges while setting a new benchmark in biotechnological research and development.
For more about Bactobio’s mission and initiatives, visit their newsroom.

Author
BioFocus Newsroom